USPTO serial 97310188
ENTAC
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- YONTEF, DAVID ERIC
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ENTAC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Anuj Desai
Anuj Desai ARNALL GOLDEN GREGORY LLP171 17TH ST NWSUITE 2100ATLANTA, GA 30363Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable mobile applications for verifying and displaying identity and health information; downloadable computer application software for mobile phones, namely, software for viewing digital image and photographic data concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; downloadable computer application software for mobile phones, namely, software for displaying health data and metrics concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; downloadable computer application software for mobile phones, namely, software for enabling health practitioners to analyze and review medical data and information before making clinical decisions in postoperative patient care situations; downloadable computer application software for mobile phones and tablets, namely, software for viewing digital image and photographic data concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; downloadable computer application software for mobile phones and tablets, namely, software for displaying health data and metrics concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; downloadable computer application software for mobile phones and tablets, namely, software for enabling health practitioners to analyze and review medical data and information before making clinical decisions in postoperative patient care situations; downloadable computer programs using artificial intelligence for viewing digital image and photographic data concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; downloadable computer programs using artificial intelligence for displaying health data and metrics concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; downloadable computer programs using artificial intelligence for enabling health practitioners to analyze and review medical data and information before making clinical decisions in postoperative patient care situations; downloadable computer software using artificial intelligence for viewing digital image and photographic data concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; downloadable computer software using artificial intelligence for displaying health data and metrics concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; downloadable computer software using artificial intelligence for enabling health practitioners to analyze and review medical data and information before making clinical decisions in postoperative patient care situations; downloadable software as a Medical Device (SaMD) for diagnosing postoperative diseases and disorders associated with a patient's digestive, pulmonary, vascular and cardiovascular systems; electronic products for the generation, measurement, and analysis of audio signals, namely, audio analyzers; recorded computer application software for medical devices containing computers therein, namely, software for displaying health data and metrics concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems and for diagnosing diseases and disorders associated therewith; recorded computer application software for medical devices containing computers therein, namely, software for enabling health practitioners to analyze and review medical data and information before making clinical decisions in postoperative patient care situations; recorded computer programs using artificial intelligence for viewing digital image and photographic data concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; recorded computer programs using artificial intelligence for displaying health data and metrics concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; recorded computer programs using artificial intelligence for enabling health practitioners to analyze and review medical data and information before making clinical decisions in postoperative patient care situations; recorded computer software using artificial intelligence for viewing digital image and photographic data concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; recorded computer software using artificial intelligence for displaying health data and metrics concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; recorded computer software using artificial intelligence for enabling health practitioners to analyze and review medical data and information before making clinical decisions in postoperative patient care situations; recorded software as a Medical Device (SaMD) for diagnosing postoperative diseases and disorders associated with a patient's digestive, pulmonary, vascular and cardiovascular systems; software as a Medical Device (SaMD), downloadable, for analyzing heart rate data; software as a Medical Device (SaMD), downloadable, for diagnosing postoperative diseases and disorders associated with a patient's digestive, pulmonary, vascular and cardiovascular systems; software as a Medical Device (SaMD), recorded, for diagnosing postoperative diseases and disorders associated with a patient's digestive, pulmonary, vascular and cardiovascular systems | ACTIVE | — |
| 010 | Medical devices for use in diagnosing postoperative diseases and disorders associated with a patient's digestive, pulmonary, vascular and cardiovascular systems; medical devices for use in treating or diagnosing postoperative diseases and disorders associated with a patient's digestive, pulmonary, vascular and cardiovascular systems with integrated recorded operating system software, sold as a unit; medical hearing instruments and parts of such devices; all of the foregoing, excluding surgical instruments and apparatus | ACTIVE | — |
| 035 | Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, providing information management services | ACTIVE | — |
| 042 | Clinical research in the field of science and medicine relating to the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; data warehousing; research and development and consultation related thereto in the field of science and medicine relating to postoperative health predictions concerning a patient's digestive, pulmonary, vascular and cardiovascular systems; research and development in the field of science and medicine relating to postoperative health predictions concerning a patient's digestive, pulmonary, vascular and cardiovascular systems; consulting services for others in the field of design, planning, and implementation project management of clinical trials for others in the field of postoperative health concerning a patient's digestive, pulmonary, vascular and cardiovascular systems; providing a web site featuring temporary use of non-downloadable software for displaying and downloading clinical data and for authorizing access to databases featuring clinical data; providing a website featuring non-downloadable software for displaying and downloading clinical data and for authorizing access to databases featuring clinical data; providing a website featuring non-downloadable software using artificial intelligence for displaying and downloading clinical data and for authorizing access to databases featuring clinical data; providing a website featuring on-line non-downloadable software that enables users to display and download clinical data and gain authorized access to databases featuring clinical data; providing a website featuring resources, namely, non-downloadable software for displaying and downloading clinical data and for authorizing access to databases featuring clinical data; providing a web site featuring technology for enabling physicians to access resources in clinical medicine; providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports; providing information in the field of clinical research via a website; providing information on clinical studies via an interactive website; providing medical and scientific research information in the field of clinical trials; providing temporary use of a web-based software application for displaying and downloading clinical data and for authorizing access to databases featuring clinical data; providing temporary use of a non-downloadable web application for displaying and downloading clinical data and for authorizing access to databases featuring clinical data; providing temporary use of on-line non-downloadable cloud computing software using artificial intelligence for displaying and downloading clinical data and for authorizing access to databases featuring clinical data; providing temporary use of on-line non-downloadable software and applications using artificial intelligence for displaying and downloading clinical data and for authorizing access to databases featuring clinical data; scientific research in the nature of conducting clinical trials for others; scientific research in the nature of conducting clinical trials for others in the field of postoperative health concerning a patient's digestive, pulmonary, vascular and cardiovascular systems | ACTIVE | — |
| 044 | Clinical medical consultation services; providing health information via a website; providing a website featuring information in the field of a patient's postoperative digestive, pulmonary, vascular and cardiovascular health; providing information in the field of a patient's postoperative digestive, pulmonary, vascular and cardiovascular health via a website | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Entac Medical, Inc.
- Other trademarks owned by Entac Medical, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ENTAC
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 2, 2026 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 2, 2026 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 2, 2026 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 2, 2026 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 7, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 6, 2026 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Mar 11, 2026 | EXT5 | SOU EXTENSION 5 FILED | — |
| Mar 11, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 26, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 25, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Sep 25, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| Sep 25, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 26, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 26, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Mar 25, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Mar 25, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 24, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 24, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 24, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 24, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 27, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 26, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 26, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 26, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 26, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 1, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 1, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 12, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 28, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 24, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 23, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 23, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 13, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Mar 13, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Dec 23, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 23, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 23, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 17, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 17, 2022 | NWAP | NEW APPLICATION ENTERED | — |